Semaglutide-based products have achieved widespread adoption across both diabetes and obesity treatment settings, supported by growing physician confidence and favorable clinical guidelines
Our roundup of the best GLP-1 tracker apps compares the top choices side by side, and our free GLP-1 tracker guide explains exactly what to log and why it matters
Injection timing and day selection Once-weekly dosing gives you flexibility in choosing your injection day
U.S.: The Food and Drug Administration (FDA) is the primary regulatory body, ensuring the safety and efficacy of incretin mimetics like Exenatide, Liraglutide, Dulaglutide, and Semaglutide
A multidisciplinary advisory from major nutrition, lifestyle medicine, obesity medicine, and obesity research organizations recommends screening dietary intake, medical conditions, strength, function, physical activity, and other lifestyle factors when initiating GLP-1 therapy